BLOOMINGTON, Ind., Jan. 19, 2017 -- Megaputer Intelligence announced today that it will host a live webinar series titled “Text Analytics for Pharma” beginning on January 31, 2017. A set of nine free webinars comprising this series will highlight how advanced text analytics helps address typical challenges encountered in the pharmaceutical and life sciences domains:
- Detection of potential adverse events
- Extraction of facts from academic publications
- Analysis of call center transcripts
- Survey data analysis
- Medical device repair notes analysis
- Competitive intelligence
- Social media analysis
Presenters will discuss the underworkings and practical implementations of advanced computational linguistics techniques, as well as the foundations of systems for the analysis of BIG DATA. Topics will be presented by data and text analysis specialists with relevant domain expertise. The webinar series is scheduled to run from January to April 2017.
The webinars will provide business practitioners with a clear understanding of frequently encountered individual tasks and outline the technology, implementation path, results, and benefits of the analytical solutions developed at industry-leading companies for addressing these tasks.
For more information and to register for the webinars, visit www.polyanalyst.com/webinars. Advance registration is encouraged, as availability is limited for each webinar.
About Megaputer Intelligence
Megaputer Intelligence (www.megaputer.com) is a leading developer of data and text mining software and custom analytical solutions for various application domains. Megaputer analytical tools enable over 500 customers worldwide to make informed data-driven decisions.
Megaputer is a registered trademark of Megaputer Intelligence Inc. in the United States and/or other countries. The names of other companies and products mentioned herein may be the trademarks of their respective owners.
For more information: Brian Howard Megaputer Intelligence, Inc. (812) 330-0110 ext. 215 [email protected]


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Apple Turns 50: From Garage Startup to AI Crossroads
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 



